团结求尊严：2030 年实现全球无麻风病目标的四大战略转变。

United for dignity: four strategic shifts to get to zero leprosy by 2030.

机构信息

Regional Adviser, Neglected Tropical Disease Control, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.

Technical Officer, Neglected Tropical Diseases, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.

出版信息

East Mediterr Health J. 2022 Feb 27;28(2):93-94. doi: 10.26719/2022.28.2.93.

DOI:10.26719/2022.28.2.93

PMID:35304905

Abstract

Leprosy, or Hansen's disease, is a curable infectious disease caused by the bacillus M. leprae. In 1991, the World Health Assembly WHA44.9 set the goal for "elimination of leprosy as a public health problem" as less than one case on treatment per 10 000 population by 2000. Since then, global leprosy strategies have focused on reducing the prevalence of the disease at country level and reducing transmission. Early detection and prompt treatment with multidrug therapy, the keystone for leprosy control, led to the achievement of this goal at global level by 2000, and in almost all countries, at least at the national level, by 2015.

摘要

麻风病，又称汉森病，是一种由麻风分枝杆菌引起的可治愈的传染病。1991 年，世界卫生大会（WHA44.9）设定了一个目标，即到 2000 年，每 10000 名治疗人口中麻风病的病例数少于 1 例，以此作为“消除麻风病作为公共卫生问题”的目标。从那时起，全球麻风病战略的重点是在国家一级降低疾病的流行率和减少传播。早期发现和及时采用多药治疗（麻风病控制的基石），导致全球在 2000 年实现了这一目标，并且在几乎所有国家，至少在国家一级，也在 2015 年实现了这一目标。